atopic dermatitis

News

Adults With and Without Atopic Dermatitis Choose Moisturizers for Personal Satisfaction

06/14/2022

According to a study, physicians should continue to educate patients with atopic dermatitis on the importance of using moisturizers to restore the skin barrier.

According to a study, physicians...

06/14/2022

The Dermatologist

News

IL4RA and Food Allergy Association Is Mediated by Atopic Dermatitis in School-Aged Children

06/14/2022

According to a study, atopic dermatitis (AD) mediates the interleukin-4 receptor alpha chain gene variant and food allergy association in school-aged children.

According to a study, atopic...

06/14/2022

The Dermatologist

News

Parents and Children with AD Prioritize Different Aspects of Emollients

06/14/2022

A study found that children with eczema and their parents evaluate emollients based on different aspects and there is no universal type for each patient.

A study found that children with...

06/14/2022

The Dermatologist

April Armstrong, MD, MPH, Dermatology Week 2022

Conference Coverage

Novel Topical PDE-4 Inhibitors For Plaque Psoriasis, Atopic Dermatitis, and Seborrheic Dermatitis

05/12/2022

Riya Gandhi , MA;

On the first day of Dermatology Week 2022, April Armstrong, MD, MPH, opened her session by noting, “There are common unmet needs in inflammatory skin diseases and that created opportunities for new well tolerated and effective topical...

On the first day of Dermatology...

05/12/2022

The Dermatologist

News

Atopic Dermatitis Associated with Cardiovascular Disease

09/24/2021

Lisa Kuhns , PhD, MD;

Patients with atopic dermatitis (AD) and metabolic disorders are at risk for developing cardiovascular disease (CVD) and major cardiovascular events (MACE), according to a study published in Dermatology and Therapy. Researchers aimed to...

Patients with atopic dermatitis...

09/24/2021

The Dermatologist

News

Increased Air Pollution Linked to AD and Chronic Inflammatory Skin Diseases

09/24/2021

Lisa Kuhns , PhD, MD;

According to a study published in Clinical and Experimental Dermatology, particulate matter (PM) is associated with atopic dermatitis (AD) and chronic inflammatory skin diseases in South Korea. Researchers aimed to investigate the...

According to a study published...

09/24/2021

The Dermatologist

Risk for SARS-CoV-2 in Patients With Atopic Dermatitis Not Increased

09/24/2021

Lisa Kuhns , PhD, MD;

SARS-CoV-2 infection rates and hospitalizations within 2 weeks of a SARS-CoV-2 test in patients with atopic dermatitis (AD) are not significantly increased from those without AD, according to a study published in British Journal of...

SARS-CoV-2 infection rates and...

09/24/2021

The Dermatologist

Crisaborole Efficacious and Well Tolerated in Patients With Mild to Moderate AD

09/24/2021

Lisa Kuhns , PhD, MD;

Crisaborole is well tolerated and effective in patients with mild to moderate atopic dermatitis (AD) and other comorbidities, according to a recent study published in Allergy and Asthma Proceedings. Researchers performed a post hoc...

Crisaborole is well tolerated...

09/24/2021

The Dermatologist

Severe AD Linked to Mental Health Outcomes Across Childhood

09/24/2021

Lisa Kuhns , PhD, MD;

Severe atopic dermatitis (AD) is associated with symptoms of depression and internalizing behaviors across childhood and adolescence. Researchers examined the association between AD and internalizing behaviors and symptoms of depression...

Severe atopic dermatitis (AD) is...

09/24/2021

The Dermatologist

News

New JAK Inhibitor Shows Efficacy, Safety in Phase 3 Trials for Atopic Dermatitis

06/01/2021

Lauren Mateja ;

Upadacitinib, an oral Janus kinase (JAK) 1 inhibitor, was found to be safe and efficacious for the treatment of atopic dermatitis (AD) in two phase 3 clinical trials. The results of the trials were published in The Lancet. The Measure Up 1...

Upadacitinib, an oral Janus...

06/01/2021

The Dermatologist